ZIM Labs develops, manufactures, and supplies differentiated generic products in oral solid dosage forms, including pre-formulation intermediates and finished formulations. They also offer pharmaceutical and nutraceutical products. The company is self-described as research-driven and focuses on innovative process technologies for patient compliance.

ZIM Laboratories Limited develops, manufactures, and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms, such as granules, pellets, taste-masked powders, suspensions, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, CNS, antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.

IN:ZIMLAB

ZIM Labs

Last Close

103.35

22/11 09:59

Market Cap

5.36B

Beta: -

Volume Today

18.85K

Avg: -

locale

market

industry

website

ipo date

peer of

Metrics